Gajanan S Inamdar PhD’s Post

View profile for Gajanan S Inamdar PhD, graphic

Organic and Medicinal Chemist | Drug Discovery | Chemistry | Executive Management | Cross-Functional Collaborator | Lead Optimization | Waterfall | R&D | Cricket | Vedic Astrology |

https://lnkd.in/gn3ph8cw In their pursuit of the most efficient construction of PF-07265807 (ARRY-067) for process development prior to commercial manufacture, the team's route scouting efforts are meticulously chronicled. At the heart of ARRY-067 lies the azaindazole (1H-pyrazolo [3,4-b]pyridine) building block, a fundamental element shared by many pharmaceuticals and bioactive agents. Their narrative unfolds with a novel approach to this intricate structural motif. A symphony of chemical ingenuity, their method orchestrates an oxazoline ring-opening cyclization cascade, revealing the target 3-alaninol-substituted azaindazole in a single step, catalyzed by the addition of hydrazine. Additionally, an optimized synthesis of the uracil carboxylic acid coupling partner is presented, enhancing the elegance of their approach. Central to their achievement is the revelation of a route six steps shorter than the enabling route. This reduction is accompanied by minimized protecting group manipulations and the avoidance of transition metal catalysis. Through this innovative journey, they not only streamline the path to ARRY-067 but also push the boundaries of synthetic chemistry, marking a significant advancement in pharmaceutical synthesis.

  • No alternative text description for this image
Raheleh Ghassem Zadeh, PhD

Consultant | Research Scientist | Metabolomics | Mass-Spectrometry | Food Chemistry | Technology Transfer | Collaboration | Competetive Intelligence | FTIR, HPLC, GC/MS | Tennis

8mo

Congratulations on the team's innovative approach, marking a significant advancement in pharmaceutical synthesis! Well done!

Like
Reply

To view or add a comment, sign in

Explore topics